MicroRNA-218 increases the sensitivity of bladder cancer to cisplatin by targeting Glut1
Cost pressures for Part D plan sponsors under the redesigned Part D benefit are likely one factor in higher costs being passed along to both PDP and MA-PD enrollees in the form of higher deductibles and greater use of coinsurance
If combining with other medications or supplements, discuss potential interactions with your provider
[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Huang S., He T., Yang S., Sheng H., Tang X., Bao F., Wang Y., Lin X., Yu W., Cheng F., et al
INFORMATION COLLECTION We collect information about users that users provide through optional, voluntary submissions to receive electronic newsletters, to submit questions and comments, to share information with a friend, and participation in polls, surveys, and ticket purchases